Vaccines
Our work in vaccines and immunization focuses on the goal of helping to make certain diseases a thing of the past.
Vaccines are one of the greatest public health success stories in history
We recognize the potential for vaccines to serve as a powerful tool — helping to protect against certain potentially serious diseases, support public health care and advance health equity.
In the U.S., we make vaccines for 10 of the serious diseases for which the Centers for Disease Control & Prevention recommends routine vaccination.
What does it mean to be pioneers?
Discovering, developing and supplying vaccines is in our DNA — for the past century and into the next one. We’re working tirelessly to help prevent infectious diseases and improve access to vaccines for a more equitable future.
Our work in vaccines
Vaccines play a critical and enduring role in global public health, helping to prevent a variety of infectious diseases and making some once-feared diseases, such as smallpox, a thing of the past. Yet, vaccine-preventable diseases and outbreaks persist in some contexts — due largely to low vaccination rates often resulting from vaccine hesitancy or challenges with access.
“We’re committed to advancing and mobilizing our scientific research and expertise, supply capacity and strong external collaborations to build awareness, trust, access and acceptance of vaccines among people everywhere.”
— Richard M. Haupt, vice president, head of global medical & scientific affairs, vaccines and infectious diseases
Our areas of focus
Legacy and leadership
For more than 100 years, our company has been a pioneer in the fight against certain vaccine-preventable diseases across the life course. Many of our vaccines are woven into the fabric of our societies as a cornerstone of public health.
Need-first approach
The infectious disease landscape is ever evolving. That’s why we go where the need is and work to find new ways to solve complex public health problems. This “need-first” mindset is the foundation of our research and development strategy.
Research and innovation
We’re investing in groundbreaking research and leveraging time-proven and new technologies and platforms to help discover new vaccines and immunizations.
End-to-end commitment
We continue to invest in manufacturing and end-to-end supply improvements in both capability and capacity to help ensure a sustainable, reliable supply of quality and affordable vaccines to serve global needs.
Collaboration
We believe that collaboration is key to fighting some of the world’s most challenging global health threats. That’s why we collaborate with stakeholders and organizations globally, regionally and locally to help support the discovery, development, supply and delivery of vaccines to people who may otherwise be without them.
